LS
Insider
Laura Shawver
DirectorLaura Shawver (Director) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in SPRY. The largest single filing was $2.7M of SPRY (199,099 sh across 3 lots, as filed), executed Dec 2 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Apr 7 2025
Filed Apr 8 2025
Volume by month
Buys $0
Sells $5.0M
Shares × price, as filed · by filing month · past 24 months
Most traded names
SPRY
SPRY
0 buys · 5 sells
5 filings
Recent filings
SPRYSALE
ARS Pharmaceuticals, Inc.
View filing →
$615K50,002 sh × $12.30
Exec Apr 7 2025
Filed Apr 8 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $556K
49,600 sh × $11.21
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $616K
50,000 sh × $12.31
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $555K
50,000 sh × $11.10
Exec Jan 6 2025
Filed Jan 7 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $2.7M
199,099 sh across 3 lots
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET